Cost of care

The End of Humira’s $200 Billion Drug Monopoly

What will happen when the best selling drug ever finally faces direct competition?

Read More

‘A Shocking Amount of Misery’: Medical Debt in America

We talk about the impact medical debt can have on people’s lives and what research tells us about possible solutions.

Read More

Drugmakers and Patient Assistance Programs: Tricks or Treats?

Stacie Dusetzina shares new research that examines the link between drug companies’ charity donations and their business incentives.

Read More

Lessons from a Trauma Center Boom in Texas

Sayeh Nikpay shares new research that examines the impact of a trauma center boom in Texas.

Read More

How Hospitals Respond to Value-based Payment

Yaa Akosa Antwi shares new research on the impact of a pay-for-performance program on hospital quality.

Read More

The Race to Prepare for Medicare’s New Drug Pricing Powers

Congress gave Medicare historic new powers to lower drug prices, but lawsuits, loopholes and opposition from the drug industry could undermine them.

Read More

Dems’ New Drug Pricing Deal: What You Need to Know

Stacie Duestzina shares key takeaways from the drug pricing provisions of the new Inflation Reduction Act.

Read More

Abortion Funds’ Growing Role Post-Roe

Independent abortion funds have been flooded with donations post-Roe. How do these funds work and what role will they play in a post-Roe world?

Read More

Good Intentions Gone Awry

Why has a little-known program designed to help hospitals and clinics that serve low-income people become so controversial?

Read More

Do Higher Hospital Prices Reflect Greater Investments in Quality?

Benedic Ippolito shares new research that examines whether hospitals with higher prices also offer higher quality care.

Read More